肠道微生物群在免疫和炎症性疾病中的作用。
Role of the gut microbiota in immunity and inflammatory disease.
机构信息
Department of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor 48109, Michigan, USA.
出版信息
Nat Rev Immunol. 2013 May;13(5):321-35. doi: 10.1038/nri3430.
The mammalian intestine is colonized by trillions of microorganisms, most of which are bacteria that have co-evolved with the host in a symbiotic relationship. The collection of microbial populations that reside on and in the host is commonly referred to as the microbiota. A principal function of the microbiota is to protect the intestine against colonization by exogenous pathogens and potentially harmful indigenous microorganisms via several mechanisms, which include direct competition for limited nutrients and the modulation of host immune responses. Conversely, pathogens have developed strategies to promote their replication in the presence of competing microbiota. Breakdown of the normal microbial community increases the risk of pathogen infection, the overgrowth of harmful pathobionts and inflammatory disease. Understanding the interaction of the microbiota with pathogens and the host might provide new insights into the pathogenesis of disease, as well as novel avenues for preventing and treating intestinal and systemic disorders.
哺乳动物的肠道中定植着数以万亿计的微生物,其中大多数为细菌,它们与宿主在共生关系中共同进化。栖息于宿主体表和体内的微生物群体通常被称为微生物组。微生物组的一个主要功能是通过多种机制保护肠道免受外源性病原体和潜在有害土著微生物的定植,这些机制包括直接竞争有限的营养物质和调节宿主免疫反应。相反,病原体已经发展出了在竞争的微生物组中促进自身复制的策略。正常微生物群落的破坏会增加病原体感染、有害共生菌过度生长和炎症性疾病的风险。了解微生物组与病原体和宿主的相互作用可能为疾病的发病机制提供新的见解,并为预防和治疗肠道和系统性疾病开辟新的途径。